Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CABR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caring Brands, Inc. filings document the company's securities registration, capital structure, governance changes, and material events as a Nasdaq-listed wellness consumer products issuer. Its S-1 registration materials describe common stock offerings, business disclosures, risk factors, financial statements, and the company's OTC and cosmetic product focus.
Recent 8-K filings cover Nasdaq continued-listing compliance, amendments to shareholder-meeting quorum requirements, executive finance-function changes, and financing transactions involving Series A Convertible Preferred Stock, common warrants, and insider share redemptions. Other event disclosures record patent-related updates for the Hair Enzyme Booster product and related intellectual property matters.
Caring Brands, Inc. director Christopher Matthew Galeta received a stock option grant on December 11, 2025 under the company’s equity incentive plan. The award covers 25,000 stock options with an exercise price of $1.13 per share, giving him the right to buy 25,000 shares of common stock at that price.
The options were approved by the Board of Directors at the recommendation of the Compensation Committee and vest immediately as of December 11, 2025. After this grant, Galeta beneficially owns 25,000 derivative securities in the form of these stock options, which expire on December 11, 2030.
Caring Brands, Inc. disclosed that its Chief Executive Officer, director, and 10% owner, Dr. Glynn Wilson, received two restricted stock unit (RSU) grants of common stock on December 11, 2025 under the company’s equity incentive plan. The first award covers 126,720 RSUs that fully vest on June 11, 2026, and the second covers 45,872 RSUs that fully vest on December 11, 2026, in each case conditioned on Dr. Wilson’s continued service with the company.
Both grants are shown at a price of $0 per share, reflecting equity compensation rather than an open‑market purchase. Following these awards, Dr. Wilson is reported as beneficially owning 2,172,592 shares of Caring Brands common stock, which includes his prior ownership of 2,000,000 shares.
Caring Brands, Inc. reported that Chief Financial Officer Tyler Thomas Moore received equity awards totaling 300,000 restricted stock units of common stock on December 11, 2025 under its equity incentive plan.
The grants consist of 270,000 restricted stock units that fully vest on June 11, 2026 and 30,000 restricted stock units that fully vest on December 11, 2026, in each case subject to his continued service with the company. Following these awards, he beneficially owns 300,000 shares of common stock directly.